Cargando…
Immune ambivalence: The schizophrenic bleomycin
In addition to cytotoxic effects, anticancer agents can exert multiple immunomodulatory functions. We have recently described the molecular mechanisms whereby bleomycin can 1) promote endoplasmic reticulum stress, causing the immunogenic death of cancer cells and hence strengthening antitumor CD8(+)...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850019/ https://www.ncbi.nlm.nih.gov/pubmed/24327935 http://dx.doi.org/10.4161/onci.25737 |
_version_ | 1782294028071469056 |
---|---|
author | Mignot, Grégoire Bugaut, Hélène Ghiringhelli, François |
author_facet | Mignot, Grégoire Bugaut, Hélène Ghiringhelli, François |
author_sort | Mignot, Grégoire |
collection | PubMed |
description | In addition to cytotoxic effects, anticancer agents can exert multiple immunomodulatory functions. We have recently described the molecular mechanisms whereby bleomycin can 1) promote endoplasmic reticulum stress, causing the immunogenic death of cancer cells and hence strengthening antitumor CD8(+) T cell responses; and 2) induce the secretion of transforming growth factor β (TGFβ), which stimulates regulatory T cells. This suggests that bleomycin may be favorably combined with TGFβ-targeting strategies. |
format | Online Article Text |
id | pubmed-3850019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-38500192013-12-10 Immune ambivalence: The schizophrenic bleomycin Mignot, Grégoire Bugaut, Hélène Ghiringhelli, François Oncoimmunology Author's View In addition to cytotoxic effects, anticancer agents can exert multiple immunomodulatory functions. We have recently described the molecular mechanisms whereby bleomycin can 1) promote endoplasmic reticulum stress, causing the immunogenic death of cancer cells and hence strengthening antitumor CD8(+) T cell responses; and 2) induce the secretion of transforming growth factor β (TGFβ), which stimulates regulatory T cells. This suggests that bleomycin may be favorably combined with TGFβ-targeting strategies. Landes Bioscience 2013-09-01 2013-07-23 /pmc/articles/PMC3850019/ /pubmed/24327935 http://dx.doi.org/10.4161/onci.25737 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Mignot, Grégoire Bugaut, Hélène Ghiringhelli, François Immune ambivalence: The schizophrenic bleomycin |
title | Immune ambivalence: The schizophrenic bleomycin |
title_full | Immune ambivalence: The schizophrenic bleomycin |
title_fullStr | Immune ambivalence: The schizophrenic bleomycin |
title_full_unstemmed | Immune ambivalence: The schizophrenic bleomycin |
title_short | Immune ambivalence: The schizophrenic bleomycin |
title_sort | immune ambivalence: the schizophrenic bleomycin |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850019/ https://www.ncbi.nlm.nih.gov/pubmed/24327935 http://dx.doi.org/10.4161/onci.25737 |
work_keys_str_mv | AT mignotgregoire immuneambivalencetheschizophrenicbleomycin AT bugauthelene immuneambivalencetheschizophrenicbleomycin AT ghiringhellifrancois immuneambivalencetheschizophrenicbleomycin |